Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

J&J's Janssen R&D LLC buys Aragon Pharmaceuticals

Executive Summary

Johnson & Johnson's Janssen R&D LLC has acquired closely held Aragon Pharmaceuticals Inc. (hormonally-driven cancer therapeutics) for $650mm in cash up front, plus earn-outs upon reaching development milestones of up to $350mm.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Includes Earnout
    • Full Acquisition
    • Payment Includes Cash

Related Companies